Anti-Cryptosporidium parvum Apical complex glycoprotein CSL Antibody (SAA2327) from ProteoGenix; catalogue ARO-A22713; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A highly effective tool for researchers in the biotech field. This cutting-edge antibody is specifically designed to target the Apical complex glycoprotein of Cryptosporidium parvum, a common parasite that can cause severe gastrointestinal illness in humans.
The biological function of this antibody is to bind to the Apical complex glycoprotein, preventing it from attaching to host cells and causing infection. This makes it a valuable tool for studying the mechanisms of Cryptosporidium parvum infection and developing potential treatments.
One of the main applications of the Anti-Cryptosporidium parvum Apical complex glycoprotein CSL Antibody is in the field of immunofluorescence microscopy. Its high specificity and sensitivity make it an ideal choice for visualizing the Apical complex glycoprotein in infected cells, allowing for detailed analysis of its localization and function.
Furthermore, this antibody has been extensively tested in various experimental use cases, demonstrating its reliability and reproducibility. It has been successfully used in both in vitro and in vivo studies, providing valuable insights into the pathogenesis of Cryptosporidium parvum and its potential vulnerabilities.
When it comes to your research, you need reliable and accurate tools to achieve your goals. The Anti-Cryptosporidium parvum Apical complex glycoprotein CSL Antibody (SAA2327) is a top choice for any researcher looking to gain a deeper understanding of this parasite and its mechanisms of infection.
Don’t settle for generic explanations – choose a high-quality antibody that will drive your research forward. Order now and discover the power of the Anti-Cryptosporidium parvum Apical complex glycoprotein CSL Antibody.
ProteoGenix catalogue number ARO-A22713. For research use only.
Target: Apical complex glycoprotein CSL, CSL (circumsporozoite-like) antigen; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Apical complex glycoprotein CSL, CSL (circumsporozoite-like) antigen |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
